These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18959617)

  • 21. Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians.
    Wolford JK; Yeatts KA; Red Eagle AR; Nelson RG; Knowler WC; Hanson RL
    Diabet Med; 2006 Apr; 23(4):367-76. PubMed ID: 16620264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide SNP genotyping study using pooled DNA to identify candidate markers mediating susceptibility to end-stage renal disease attributed to Type 1 diabetes.
    Craig DW; Millis MP; DiStefano JK
    Diabet Med; 2009 Nov; 26(11):1090-8. PubMed ID: 19929986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resequencing of the characterised CTGF gene to identify novel or known variants, and analysis of their association with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Brady HR; Maxwell AP
    J Hum Genet; 2006; 51(4):383-386. PubMed ID: 16501850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathy.
    Hyvönen ME; Ihalmo P; Forsblom C; Thorn L; Sandholm N; Lehtonen S; Groop PH
    Diabet Med; 2012 Dec; 29(12):1589-95. PubMed ID: 22486725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.
    Möllsten A; Vionnet N; Forsblom C; Parkkonen M; Tarnow L; Hadjadj S; Marre M; Parving HH; Groop PH
    Mol Genet Metab; 2011 May; 103(1):66-70. PubMed ID: 21316998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between variation in the actin-binding gene caldesmon and diabetic nephropathy in type 1 diabetes.
    Conway BR; Maxwell AP; Savage DA; Patterson CC; Doran PP; Murphy M; Brady HR; Fogarty DG
    Diabetes; 2004 Apr; 53(4):1162-5. PubMed ID: 15047636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.
    Maltais I; Bachvarova M; Maheux P; Perron P; Marceau F; Bachvarov D
    Can J Physiol Pharmacol; 2002 Apr; 80(4):323-7. PubMed ID: 12025967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy.
    Pettigrew KA; McKnight AJ; Patterson CC; Kilner J; Sadlier DM; Maxwell AP
    J Hum Genet; 2010 Apr; 55(4):248-51. PubMed ID: 20203694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes.
    Patente TA; Mohammedi K; Bellili-Muñoz N; Driss F; Sanchez M; Fumeron F; Roussel R; Hadjadj S; Corrêa-Giannella ML; Marre M; Velho G
    Free Radic Biol Med; 2015 Sep; 86():16-24. PubMed ID: 25862415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic association analyses of non-synonymous single nucleotide polymorphisms in diabetic nephropathy.
    Savage DA; Patterson CC; Deloukas P; Whittaker P; McKnight AJ; Morrison J; Boulton AJ; Demaine AG; Marshall SM; Millward BA; Thomas SM; Viberti GC; Walker JD; Sadlier D; Maxwell AP; Bain SC
    Diabetologia; 2008 Nov; 51(11):1998-2002. PubMed ID: 18773191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect.
    Mlynarski WM; Placha GP; Wolkow PP; Bochenski JP; Warram JH; Krolewski AS
    Diabetes; 2005 Nov; 54(11):3331-5. PubMed ID: 16249462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of neuropeptide Y Leu7Pro polymorphism in patients with type 1 diabetes and diabetic nephropathy among Swedish and American populations.
    Ma J; Nordman S; Möllsten A; Falhammar H; Brismar K; Dahlquist G; Efendic S; Gu HF
    Eur J Endocrinol; 2007 Nov; 157(5):641-5. PubMed ID: 17984244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACE variants interact with the RAS pathway to confer risk and protection against type 2 diabetic nephropathy.
    Ahluwalia TS; Ahuja M; Rai TS; Kohli HS; Bhansali A; Sud K; Khullar M
    DNA Cell Biol; 2009 Mar; 28(3):141-50. PubMed ID: 19108684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathy.
    Chen JW; Hansen PM; Tarnow L; Hellgren A; Deckert T; Pociot F
    Diabet Med; 1997 Feb; 14(2):143-7. PubMed ID: 9047092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant correlation between association of polymorphism in codon 10 of transforming growth factor-beta1 T (29) C with type 1 diabetes and patients with nephropathy disorder.
    Jahromi MM; Millward BA; Demaine AG
    J Interferon Cytokine Res; 2010 Feb; 30(2):59-66. PubMed ID: 20039825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of genetic variability at the ACE locus in intron 16 on Diabetic Nephropathy in T1DM patients.
    Parchwani DN; Kesari MG; Patel DD; Patel DJ
    Indian J Physiol Pharmacol; 2014; 58(4):327-37. PubMed ID: 26214998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Wanic K; Placha G; Dunn J; Smiles A; Warram JH; Krolewski AS
    Diabetes; 2008 Sep; 57(9):2547-51. PubMed ID: 18753673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population.
    Wang JG; Staessen JA; Barlassina C; Fagard R; Kuznetsova T; Struijker-Boudier HA; Zagato L; Citterio L; Messaggio E; Bianchi G
    Kidney Int; 2002 Dec; 62(6):2152-9. PubMed ID: 12427140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No support for association of protein kinase C, beta 1 (PRKCB1) gene promoter polymorphisms c.-1504C>T and c.-546C>G with diabetic nephropathy in Type 1 diabetes.
    Pettigrew KA; McKnight AJ; Martin RJ; Patterson CC; Kilner J; Sadlier D; Maxwell AP; Savage DA;
    Diabet Med; 2008 Sep; 25(9):1127-9. PubMed ID: 18937679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.